WASHINGTON – Disability rights groups fear a death penalty case before the Supreme Court could have implications for the intellectually disabled far beyond the criminal context. The justices are ...

The CEO of Happy Returns, a UPS-owned company that processes boxless returns, explains how they are testing an AI fraud detection tool this holiday season with a handful of clients including apparel ...

A mom has revealed how a simple camera flash could detect a rare childhood cancer that her twins were diagnosed with at just 3 weeks old. Within days of welcoming her twin daughters, Maryann Oakley’s ...

The Supreme Court on Wednesday grappled with where the line should be drawn on intellectual disability when the death penalty is on the table in a case that could make it harder for convicted killers ...

The case involves an Alabama man who challenged his death sentence after a murder conviction because of his varying results in a series of I.Q. tests. By Ann E. Marimow Reporting from Washington The ...

Hot off the trail of National Breast Cancer Month in October, one company is trying to ease the detection of the disease that has been projected to impact at least 316,950 women across the country in ...

For half a century, the U.S. has been achieving one of the most important civil rights victories most Americans have never heard of: closing the large institutions that once warehoused people with ...

The U.S. Supreme Court is set to hear arguments in a case that advocates say could have major implications for how intellectual disability is defined. The high court will consider Hamm v. Smith on ...

Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily. On Wednesday, the Supreme Court will hear oral arguments in Hamm v. Smith, a death ...

Joseph Boden receives funding from the New Zealand Ministry of Business, Innovation and Employment, and the Health Research Council of New Zealand. He is affiliated with the Harm Reduction Coalition ...

Study of 99 pediatric patients found clinically significant CNVs in 30% of cases, supporting CMA as a first-tier test for developmental delay and ID. Clinically significant CNVs were identified in 30% ...